These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 29878889)

  • 1. Quality Control-Sterile Compounding: Analytical Methods. Density Determinations and Quality Control in Nonsterile and Sterile Compounding.
    Allen LV
    Int J Pharm Compd; 2018; 22(3):206-217. PubMed ID: 29878889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated endotoxin testing program for high-risk-level compounded sterile preparations at an institutional compounding pharmacy.
    Cooper JF; Latta KS; Smith D
    Am J Health Syst Pharm; 2010 Feb; 67(4):280-6. PubMed ID: 20133532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. USP general chapter <797> pharmaceutical compounding-sterile preparations.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
    [No Abstract]   [Full Text] [Related]  

  • 4. Basics of Compounding for Sterile, Nonsterile, and Quality Control Compounding: Process Analytical Technology: Appropriate for Sterile and Nonsterile Compounding?
    Allen LV
    Int J Pharm Compd; 2019; 23(2):123-130. PubMed ID: 31085778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basics of sterile compounding: bubble point testing.
    Thoma L
    Int J Pharm Compd; 2014; 18(1):54-7. PubMed ID: 24881342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of two work practice changes on the microbial contamination rates of pharmacy-compounded sterile preparations.
    Trissel LA; Gentempo JA; Saenz LM; Woodard MY; Angeles CH
    Am J Health Syst Pharm; 2007 Apr; 64(8):837-41. PubMed ID: 17420200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies.
    Kastango ES
    JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):38S-39S. PubMed ID: 22275322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sterile Product Packaging and Delivery Systems.
    Akers MJ
    Int J Pharm Compd; 2015; 19(6):491-500. PubMed ID: 26891564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals.
    Hung JC
    J Nucl Med; 2004 Jun; 45(6):21N-6N. PubMed ID: 15181115
    [No Abstract]   [Full Text] [Related]  

  • 10. Basics of sterile compounding: compounding by weight versus compounding by volume.
    Thoma L
    Int J Pharm Compd; 2014; 18(2):131-4. PubMed ID: 24881117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Need for specific-gravity values in adopting gravimetric measurement in sterile compounding.
    Roberts PA; Valgus JM; Willoughby IR; Amerine LB
    Am J Health Syst Pharm; 2017 Jun; 74(12):871-872. PubMed ID: 28596223
    [No Abstract]   [Full Text] [Related]  

  • 12. Basics of Sterile Compounding. Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 2.
    Martin M
    Int J Pharm Compd; 2018; 22(6):475-478. PubMed ID: 30384348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bacteriological quality of air in a ward for sterile pharmaceutical preparations].
    Caorsi P B; Sakurada Z A; Ulloa F MT; Pezzani V M; Latorre O P
    Rev Chilena Infectol; 2011 Feb; 28(1):14-8. PubMed ID: 21526280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential for airborne contamination in turbulent- and unidirectional-airflow compounding aseptic isolators.
    Peters GF; McKeon MR; Weiss WT
    Am J Health Syst Pharm; 2007 Mar; 64(6):622-31. PubMed ID: 17353571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality Assurance and Quality Control, Part 2.
    Akers MJ
    Int J Pharm Compd; 2015; 19(3):215-21. PubMed ID: 26714362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies.
    Yoch D
    Int J Pharm Compd; 2017; 21(2):95-102. PubMed ID: 28346203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dry-heat Depyrogenation Ovens for Pharmaceutical Compounding Facilities.
    Weller T; Kragseth R; Dullinger R; Illum H; Perry A
    Int J Pharm Compd; 2015; 19(3):182-92. PubMed ID: 26714359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of compounding on sterility and stability of drugs.
    Hardee GE
    J Am Vet Med Assoc; 1994 Jul; 205(2):224-5. PubMed ID: 7928582
    [No Abstract]   [Full Text] [Related]  

  • 19. Microbiological validation of a robot for the sterile compounding of injectable non-hazardous medications in a hospital environment.
    Sabatini L; Paolucci D; Marinelli F; Pianetti A; Sbaffo M; Bufarini C; Sisti M
    Eur J Hosp Pharm; 2020 Mar; 27(e1):e63-e68. PubMed ID: 32296508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Thirtieth report.
    World Health Organ Tech Rep Ser; 1987; 748():1-50. PubMed ID: 3111103
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.